PBYI vs BIIB: Which Stock is Better?
Side-by-side comparison of Puma Biotechnology Inc and Biogen Inc in 2026
PBYI
Puma Biotechnology Inc
$7.24
BIIB
Biogen Inc
$176.02
Key Metrics Comparison
| Metric | PBYI | BIIB | Winner |
|---|---|---|---|
| Market Cap | $380.56M | $25.83B | BIIB |
| P/E Ratio | 12.47 | 20.05 | PBYI |
| EPS (TTM) | $0.60 | $8.78 | BIIB |
| Revenue Growth | 0.3% | -0.1% | PBYI |
| Gross Margin | 74.5% | 78.9% | BIIB |
Analyze PBYI
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBYI or BIIB a better investment?
Comparing PBYI and BIIB: Puma Biotechnology Inc has a market cap of $380.56M while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBYI and BIIB?
PBYI (Puma Biotechnology Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBYI or BIIB?
Based on P/E ratios, PBYI trades at a lower multiple (12.5x vs 20.0x).
Which is growing faster: PBYI or BIIB?
PBYI has higher revenue growth at 0.3% vs -0.1% for BIIB.
Which company is more profitable: PBYI or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 74.5% for PBYI.
Which is the larger company: PBYI or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $380.56M for PBYI.
Should I buy PBYI or BIIB in 2026?
Both PBYI and BIIB have investment merit. PBYI trades at $7.24 while BIIB trades at $176.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBYI and BIIB stock?
Key differences: Market Cap ($380.56M vs $25.83B), P/E Ratio (12.5x vs 20.0x), Revenue Growth (0.3% vs -0.1%), Gross Margin (74.5% vs 78.9%).